Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.

A review will be made from the medical records, radiological imaging, and histological data of these patients

Inclusion Criteria:

• Age ≥ 18 years
• Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
• Availability of imaging and clinical data
• Availability of at least one follow-up during the last 12 months form diagnosis

Exclusion Criteria:

• At least one inclusion creteria not met